Nabota is a botulinum toxin type A made by Daewoong Pharmaceutical in South Korea, with the development code DWP-450. Its distinctive point: in the United States it is marketed by Evolus as Jeuveau, which the FDA approved in 2019 for glabellar (frown) lines. That sets it apart from many Korean toxins.

What is Nabota, and why does Jeuveau matter?

Nabota is a freeze-dried botulinum toxin type A developed by Daewoong, tracked in research under the code DWP-450. The same toxin is sold in the United States as Jeuveau, marketed by Evolus, and that is the part worth understanding. Jeuveau received FDA approval in 2019 for moderate to severe glabellar lines, the frown lines between the brows.

That approval is the real distinction. Most Korean toxins you read about, sold under various export names, are not FDA-approved and reach other markets through import channels. Nabota, by way of its Jeuveau identity, is a Korean-developed toxin that cleared a US regulatory review for a specific cosmetic indication. The brand you see often depends on the country.

Log Notes. This explains what Nabota is and its regulatory status, not how to use it. It gives no doses, units, dilution, injection points, depth, or frequency, all of which belong to a licensed professional. Approval for one indication in one country is not blanket clearance. Nothing here is medical advice, and this is not a do-it-yourself procedure.

How does botulinum toxin type A work?

It temporarily relaxes targeted muscles. Botulinum toxin type A blocks the release of acetylcholine at the neuromuscular junction, the signal that triggers a muscle to contract. The Cleveland Clinic’s overview of botulinum toxin injections describes how this temporarily reduces movement in the treated area, with the effect easing over weeks to months as nerve signaling returns.

Nabota has been studied for facial aesthetic use, including the masseter, beyond its approved glabellar indication. Here is the honest framing: an approval covers a specific indication and population, while many real-world uses are off-label and decided case by case. The fact that a toxin is approved somewhere does not mean every use is approved, and it does not replace a professional’s judgment about whether it suits you.

What should you expect, and what is worth tracking?

A predictable arc and a careful record. The relaxing effect builds over days, holds, then fades, so session-to-session comparison is what tells the story. If you are weighing it for frown lines, our note on Botox for forehead wrinkles and the general what Botox can do overview help set expectations.

So what belongs in the log? Begin with how long the effect actually lasted for you. The published timelines are averages across many people, and your personal duration may run shorter or longer. Note the date results began to fade and count back to your last session to find your own range.

Photographs are useful only when they are consistent. Shoot the same angle, the same lighting, and a neutral expression each time, ideally at the same hour. A steady before-and-after pair is far more reliable than a memory or a good-mirror day. Sloppy, mismatched photos rarely tell you anything trustworthy.

Add a quick self-rating before your next visit as well. A simple score on how relaxed the area still feels, plus a note on whether you would keep the same approach, gives your professional concrete feedback. Always record which brand was used, whether labeled Nabota or Jeuveau. That single note is what lets you compare fairly if you ever switch products later.

This is the kind of cycle Dosefi is built to track. Add Nabota or Jeuveau as a treatment, log each session with a date and photo, set a reminder for when the effect tends to ease, and let your self-rated trend lines build over time. To compare positioning, see our posts on Botulax and Innotox.

A grounded takeaway

Nabota is Daewoong’s botulinum toxin type A, distinctive because its US identity, Jeuveau, holds FDA approval for frown lines, unlike many import-only Korean toxins. Treat that approval as specific, not universal, keep a dated record, and route candidacy, dosing, and the procedure to a licensed professional who knows your history.

Sources